سعر ام ام ار اي 2026

Live attenuated measles, mumps and rubella vaccine (M-M-R II), lyophilized powder vial with sterile diluent, Merck Sharp & Dohme.

• Active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.Population: ≥12 monthsDailyMed (U.S. National Library of Medicine)

• Common: injection-site pain, fever, rash. Less common: transient thrombocytopenia, arthralgia/arthritis. Serious allergic and neurologic events reported rarely.International label, same product · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any vaccine component (including gelatin) or anaphylaxis to neomycin; prior hypersensitivity to MMR-containing vaccine.International label, same product · DailyMed (U.S. National Library of Medicine)
• Immunodeficiency or immunosuppression due to disease or therapy.International label, same product · DailyMed (U.S. National Library of Medicine)
• Moderate or severe febrile illness; active untreated tuberculosis; pregnancy.International label, same product · DailyMed (U.S. National Library of Medicine)

• Risk of fever and febrile seizure in the first 2 weeks after immunization; caution with history of febrile seizures.International label, same product · DailyMed (U.S. National Library of Medicine)
• Immune globulins and other blood products should not be given concurrently; they may interfere with the immune response.International label, same product · DailyMed (U.S. National Library of Medicine)

• Contraindicated in pregnancy; avoid pregnancy for 1 month after vaccination. Live vaccine viruses; wild-type infections in pregnancy associated with adverse maternal/fetal outcomes.International label, same product · DailyMed (U.S. National Library of Medicine)
• It is not known whether measles or mumps vaccine virus is secreted in human milk; rubella vaccine virus may be secreted and transmitted to breast-fed infants (usually mild).International label, same product · DailyMed (U.S. National Library of Medicine)